Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    D
  • Dapagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formAmorphous

    CAS No.461432-26-8

    View more
  • Dapagliflozin propanediol monohydrate

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline SC-3

    CAS No.960404-48-2

    View more
  • E
  • Empagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline anhydrous

    CAS No.864070-44-0

    View more
  • L
  • Linagliptin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMix of form A & B

    CAS No.668270-12-0

    View more